Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

You are here: Home » Top Stories

Top Stories

Recent articles that are of ongoing interest...

Recent Articles

  Aslan Pharma Plans $40 Million Taiwan IPO in May
  Beijing's Creat Pays $1.3 Billion for Biotest, a German Plasma Company
  Fosun Says its M&A/Operating Strategy Designed to Meet Next-Gen Business World
  C-Bridge Capital and Tasly Invest $150 Million in Two China Biopharmas
  Ally Bridge Backs $301 Million Privatization of Luoxin Pharma
  BeiGene Forms $330 Million JV for Guangzhou Biologics Manufacturing Facility
  BioSense Inks $68 Million Deal for Neovacs’ Autoimmune Disease Vaccine in China
  Sanpower and CITIC to Raise $2.9 Billion for Sanpower's Healthcare M&A
  Week in Review: China's Sanpower Pays $820 for Provenge, a Prostate Immunotherapy
  Fosun Forms $95 Million China CAR-T JV with Kite Pharma